GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » E10

Hyundai Bioscience Co (XKRX:048410) E10 : ₩-179.10 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hyundai Bioscience Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩30.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩-179.10 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 14.10% per year. During the past 5 years, the average E10 Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hyundai Bioscience Co was 30.80% per year. The lowest was 14.10% per year. And the median was 16.90% per year.

As of today (2024-06-08), Hyundai Bioscience Co's current stock price is ₩19570.00. Hyundai Bioscience Co's E10 for the quarter that ended in Mar. 2024 was ₩-179.10. Hyundai Bioscience Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Hyundai Bioscience Co was 0.02. The lowest was 0.02. And the median was 0.02.


Hyundai Bioscience Co E10 Historical Data

The historical data trend for Hyundai Bioscience Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co E10 Chart

Hyundai Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -353.17 -290.85 -171.11 -187.44 -184.61

Hyundai Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -186.53 -179.32 -181.65 -184.61 -179.10

Competitive Comparison of Hyundai Bioscience Co's E10

For the Biotechnology subindustry, Hyundai Bioscience Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyundai Bioscience Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hyundai Bioscience Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hyundai Bioscience Co's Shiller PE Ratio falls into.



Hyundai Bioscience Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hyundai Bioscience Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=30/118.8477*118.8477
=30.000

Current CPI (Mar. 2024) = 118.8477.

Hyundai Bioscience Co Quarterly Data

per share eps CPI Adj_EPS
201406 -26.000 99.353 -31.102
201409 4.000 99.608 4.773
201412 -63.000 99.098 -75.556
201503 5.000 99.720 5.959
201506 10.000 100.050 11.879
201509 31.000 100.110 36.802
201512 -23.000 100.220 -27.275
201603 5.000 100.560 5.909
201606 -9.000 100.790 -10.612
201609 -70.000 101.460 -81.996
201612 -192.000 101.560 -224.683
201703 -37.000 102.850 -42.755
201706 2.000 102.610 2.316
201709 19.000 103.490 21.820
201712 51.000 102.990 58.853
201803 -10.000 104.100 -11.417
201806 4.000 104.130 4.565
201809 25.000 105.650 28.123
201812 60.000 104.350 68.336
201903 16.000 104.490 18.199
201906 9.000 104.880 10.199
201909 24.000 105.200 27.114
201912 -16.000 105.120 -18.089
202003 -33.000 105.540 -37.161
202006 -5.000 104.870 -5.666
202009 -9.000 106.200 -10.072
202012 -183.000 105.765 -205.636
202103 -56.000 107.357 -61.994
202106 -54.000 107.579 -59.657
202109 -53.000 108.759 -57.916
202112 -349.561 109.676 -378.792
202203 -55.000 111.806 -58.464
202206 -149.000 114.083 -155.223
202209 85.000 114.831 87.973
202212 -283.000 115.200 -291.960
202303 -53.000 116.550 -54.045
202306 -59.000 117.140 -59.860
202309 -50.000 119.111 -49.889
202312 -204.000 118.848 -204.000
202403 30.000 118.848 30.000

Add all the adjusted EPS together and divide 10 will get our e10.


Hyundai Bioscience Co  (XKRX:048410) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Hyundai Bioscience Co was 0.02. The lowest was 0.02. And the median was 0.02.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hyundai Bioscience Co E10 Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Bioscience Co (XKRX:048410) Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines